Pharmanovia is a dynamic, agile, and fast-growing international pharmaceutical company dedicated to enhancing patient health worldwide through the revitalisation, extension, and expansion of established medicines and the commercialisation of novel pharmaceuticals. With a diverse portfolio of over 20 brands operating in more than 160 markets, Pharmanovia focuses on therapeutic areas such as Cardiology, Endocrinology, CNS, and Oncology.

Services include:
– Finished Dosage Forms
– Active Pharmaceutical Ingredients

Pharmanovia is committed to delivering high-quality pharmaceutical solutions that meet the evolving needs of the industry. For more information, please visit pharmanovia.com.